Acessibilidade / Reportar erro

Rates and reasons for blood donor deferral, Shiraz, Iran. A retrospective study

Taxas e razões para o diferimento de doadores de sangue, Shiraz, Irã. Um estudo retrospectivo

Abstracts

CONTEXT AND OBJECTIVE:

Knowledge of the reasons for donor deferral can help in planning more efficient recruitment strategies and evaluating donor selection criteria. This study aimed to investigate the rates and reasons for donor deferral.

DESIGN AND SETTING:

Retrospective study at Shiraz Blood Transfusion Center, Shiraz, Iran.

METHODS:

141,820 volunteers were interviewed confidentially by physicians before blood donation. The rate of and reasons for donor deferral were investigated according to demographic characteristics. The data were analyzed using the comparison-of-proportions test of the MedCalc statistical software.

RESULTS:

43,839 people (30.9%) who had come for blood donation were deferred, 1,973 (4.5%) of them permanently. The deferral rate was significantly higher among women, single individuals and first-time donors, compared with men, married individuals and those with a history of previous donation (P < 0.0001). The deferral rate was significantly higher in the 17 to 30-year-old group (P < 0.05). The reasons for deferral were divided into five categories: risk factors possibly related to HIV or hepatitis (43.6%), underlying diseases (31.9%), non-eligible conditions (13.5%), medications that interfere with blood donation (7.8%) and risk factors that may relate to bacterial or viral infections except HIV and hepatitis infections (3.2%).

CONCLUSION:

Effective measures are required for documenting the impact of deferral on blood availability, monitoring the effectiveness of and need for deferral, and determining the reasons and rates of deferral.

Blood donors; Blood safety; Donor selection; Blood supply [subheading]; Blood transfusion


CONTEXTO E OBJETIVO:

Conhecimentos sobre os motivos do adiamento da doação de sangue podem ajudar a planejar estratégias mais eficientes de recrutamento e avaliar critérios de seleção de doadores. O objetivo foi investigar as taxas e os motivos para o adiamento da doação.

TIPO DE ESTUDO E LOCAL:

Estudo retrospectivo no centro de transfusão de sangue de Shiraz, Irã.

MÉTODOS:

141.820 voluntários foram entrevistados confidencialmente por médicos antes da doação de sangue. A taxa e as razões para o adiamento da doação foram pesquisadas de acordo com características demográficas. Os dados foram analisados com o teste de comparação de proporções do software estatístico MedCalc.

RESULTADOS:

43.839 pessoas (30.9%) encaminhadas para doação tiveram sua doação diferida, sendo 1.973 permanentemente. A taxa de adiamento foi significativamente maior entre as mulheres, solteiras e doadoras de primeira vez, em comparação com os homens, casados e os com história de doação anterior (P < 0,0001). A taxa de adiamento foi significativamente maior no grupo de 17-30 anos de idade (P < 0,05). As razões para o adiamento foram divididas em cinco categorias: fatores de risco que podem estar relacionados com HIV ou hepatite (43,6%), doenças subjacentes (31,9%), condições não elegíveis (13,5%), medicamentos que interferem na doação (7,8%) e fatores de risco que podem estar relacionados com infecções bacterianas ou virais, exceto infecções de HIV e hepatite (3,2%).

CONCLUSÃO:

São necessárias medidas eficazes para documentar o impacto do diferimento na disponibilidade de sangue, monitorar eficácia e necessidade de adiamento e determinar as razões e as taxas de diferimento.

Doadores de sangue; Segurança do sangue; Seleção do doador; /irrigação sanguínea; Transfusão de sangue


INTRODUCTION

Blood safety is a major concern all over the world. One of the most important steps used to ensure blood safety is blood donor selection.11. Newman B. Blood donor suitability and allogeneic whole blood donation. Transfus Med Rev. 2001;15(3):234-44.

2. Zou S, Musavi F, Notari EP 4th, et al. Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study. Transfusion. 2005;45(10):1593-600.

3. Eder A, Bianco C. Screening blood donors: Science, reason, and the donor history questionnaire. Bethesda: American Association of Blood Banks; 2007.

4. Cable R, Musavi F, Notari E, Zou S, ARCNET Research Group. Limited effectiveness of donor deferral registries for transfusion-transmitted disease markers. Transfusion. 2008;48(1):34-42.
- 55. Zou S, Musavi F, Notari EP, et al. Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006. Transfusion. 2008;48(12):2531-9. Blood donor eligibility is determined by medical interview, based on national guidelines for donor selection.66. Katz L, Strong DM, Tegtmeier G, Stramer S. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen. Transfusion. 2008;48(11):2315-22. Donor screening criteria are established to pro tect both donors and recipients.77. Wu Y, Glynn SA, Schreiber GB, et al. First-time blood donors: demographic trends. Transfusion. 2001;41(3):360-4. To ensure blood safety, safe donors need to be recruited and high-risk donors should be discouraged from donation.88. Arslan O. Whole blood donor deferral rate and characteristics of the Turkish population. Transfus Med. 2007;17(5):379-83.

Donor selection, aimed at identifying donors who are in the window period of infectious diseases, is one of the main measures used to improve blood safety.55. Zou S, Musavi F, Notari EP, et al. Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006. Transfusion. 2008;48(12):2531-9. In spite of the importance of blood donor selection for blood safety, selection processes have negative impacts on blood supply because many deferred donors do not return to donate again, because of negative feelings toward their deferral.99. Brecher MG. AABB technical manual. 15th edition. Bethesda: AABB Press; 2005.

10. Agnihotri N. Whole blood donor deferral analysis at a center in Western India. Asian J Transfus Sci. 2010;4(2):116-22.
- 1111. Sundar P, Sangeetha SK, Seema DM, Marimuthu P, Shivanna N. Pre-donation deferral of blood donors in South Indian set-up: An analysis. Asian J Transfus Sci. 2010;4(2):112-5.

Deferral rates and the reasons for deferral vary from one center to another.1111. Sundar P, Sangeetha SK, Seema DM, Marimuthu P, Shivanna N. Pre-donation deferral of blood donors in South Indian set-up: An analysis. Asian J Transfus Sci. 2010;4(2):112-5. Better knowledge of the reasons and rates of donor deferral can help in designing more efficient recruitment strategies.

OBJECTIVE

We investigated the deferral rate and the reasons for donor defer ral among blood donors, according to demographic characteris tics, in Shiraz (southwestern Iran).

METHODS

This retrospective cross-sectional study was conducted from March 21, 2009, to March 21, 2010, at Shiraz Blood Transfusion Center, one of the main transfusion centers in Iran. The Institutional Ethics Review Committee of the Blood Transfusion Organization approved the study protocol. Before donation, those who had come for blood donation read brochures and pamphlets about blood safety and blood donation criteria. After reading these pamphlets, they made a decision whether to donate blood and register for donation. All individuals who had come for blood donation were interviewed by physicians, and all inter views took place in privacy. The physician assured donors that all their information would be kept confidential. The authors of this paper also made sure that the data remained confidential.

Standard operating procedures (SOP) based on national guidelines were used for donor selection and deferral. Donor hemoglobin (Hb) was checked using the HemoCue Hb 201 (HemoCue AB, Angelholm, Sweden). The cutoff point for Hb was 12.5 g/dl. The interview data were entered into the "Negare" software (version 4.56), which was developed in the Iran Blood Transfusion Organization (IBTO). At the end of the interview, acceptance or deferral of donors and the reasons for deferral were entered into the database. If the donor was deferred temporarily, the length of the deferral period in days was recorded. During the deferral period, donors were not allowed to donate. Confidential self-exclusion (CSE) is used in the center, and the physicians informed donors about this option. In accordance with the IBTO CSE policy, donors can choose that their blood should not be used, and a mailbox for their CSE forms is located at the entrance to the donation room after they are interviewed by physicians. The reasons for deferral were divided into five categories:

  • 1) Risk factors that may relate to HIV or hepatitis infections (high-risk sexual contacts, bloodletting, intravenous drug abuse, receiving blood in year prior to donation, presence of hepatitis after the age of 11 years, presence of hepatitis in a family member, history of jaundice, tattooing, sexually transmitted diseases, previous positive results in pre-donation screening or confirmatory tests, history of jail or prison for more than 72 hours in the preceding year or history of endoscopy).

  • 2) Underlying diseases (anemia, unsuitable blood pressure, endocrine diseases, allergy, epilepsy, diabetes mellitus, psychological diseases, gastrointestinal diseases, autoimmune diseases, asthma, respiratory diseases, coronary artery diseases, renal diseases, cardiopulmonary disease, metabolic diseases, surgery, rheumatological diseases, coagulation disorders, dermatological diseases, neurological diseases, malignancy, blood disorders, chemical war injuries or receipt of allograft transplant).

  • 3) Medication used (drug, vaccination or hormone).

  • 4) Non-eligible general condition (unsuitable criteria for donation, fasting, unsuitable blood donation or plateletpheresis or plasmapheresis interval, unsuitable weight, unsuitable age, restriction due to job, pregnancy, menstruation, breastfeeding, repeated fainting, unsuitable vein for phlebotomy or previous confidential self-exclusion).

  • 5) Risk factors that may relate to viral or bacterial infections, except HIV and hepatitis (common cold, history of traveling to places endemic for malaria, history of malaria, fever, undergoing dental treatment, history of bacterial infections or history of viral infections).

Donors between 17 and 65 years of age were eligible for donation. All of the donors were volunteers and all of them were allogeneic blood donors. The computerized records of individuals who had come for blood donation were analyzed to estimate the types of deferral (permanent or temporary). The characteristics of deferred and accepted donors were compared. The most common reasons for deferral were determined according to the demographic characteristics (educational level, donation status, sex and age). The data were analyzed using the MedCalc statistical software, with comparison of proportions, and P values less than 0.05 were considered significant.

RESULTS

From March 21, 2009, to March 21, 2010, 141,820 individ uals came to the center for blood donation. Most of the peo ple presenting for blood donation were male (93.74% ver sus 6.26%); 48.2% (68,376) were first-time donors and 22.1% (31,363) had university-level education. The characteristics of the individuals presenting for blood donation are expressed in Table 1. Out of the entire group, 43,839 (30.9%) were deferred from donation. Among the deferred donors, 4.5% (1,973) were deferred permanently.

Table 1
Characteristics of the individuals who came for blood donation

The deferral rates are summarized in Table 2 . The deferral rate was significantly higher among women (38.6% versus 29.5%), single individuals (52.9% versus 21.07%), first-time donors (48.2% versus 13.1%) and donors with low education levels (30.7% versus 27.4%), compared with men, married individuals, those with a history of previous donation and highly educated donors (P < 0.0001). The deferral rate was also significantly higher in the 17 to 30-year-old group (P < 0.0001). The top five reasons for deferral were risk factors that might relate to HIV or hepatitis infections (43.6%), underlying diseases (31.9%), non-eligible general conditions (13.5%), medications interfering with blood donation (7.8%) and risk factors that might relate to bacterial or viral infections except for HIV and hepatitis (3.2%). Among women, 25.8% were deferred because of anemia. The top three deferral reasons according to demographic characteristics are summarized in Table 3. In this study, the most common reason for deferral among men was risk factors that might relate to HIV or hepatitis infections (43.07%) and, among women, it was underlying diseases (60.4%). In our study population, the most common leading cause of short-term deferral was risk of HIV infection (38.2%), and in our permanently deferred donors, the most frequent reasons for deferral were positive results in previous screening tests for HIV, hepatitis B or hepatitis C (22.7%). The most common reason for deferral among first-time donors was risk factors that might relate to HIV or hepatitis infections (47.74%), and among donors with a history of previous donation, it was underlying diseases (36.6%).

Table 2
Deferral rates among donors according to demographic characteristics

Table 3
The three most frequent reasons for deferral according to demographic characteristics

DISCUSSION

Blood donor deferral leads to loss of available blood units for transfusion. In this study, the deferral rate was 30.9%. The deferral rates elsewhere in Asia have been found to be 14.6% in Turkey;88. Arslan O. Whole blood donor deferral rate and characteristics of the Turkish population. Transfus Med. 2007;17(5):379-83. 11.6%, 16.4% and 9% in different studies in India;10,12,13 and 14.4% in Singapore.1414. Lim JC, Tien SL, Ong YW. Main causes of pre-donation deferral of prospective blood donors in the Singapore Blood Transfusion Service. Ann Acad Med Singapore. 1993;22(3):326-31. Reports from the United States have found defer ral rates of 12.8% among a total of 47,814,370 blood donors between 2001 and 2006;5 13.6% in a study on 116,165 blood donors;15 and 15.6% in a study on 586,159 donors.16 The deferral rate in a European study was 10.8%.1717. Lawson-Ayayi S, Salmi LR. Epidemiology of blood collection in France. Eur J Epidemiol. 1999;15(3):285-92. The deferral rate in our cen ter is much higher than other studies and even much higher than

in other studies in the same geographical region, like in Turkey. All of the blood donors in our center were volunteers, but the donors in Turkey were both replacement blood donors and vol unteers. The differences in deferral rate cannot be explained through this. The differences might also be because of marked differences in blood donor eligibility criteria, lack of knowledge among donors regarding the criteria for donation, greater cau tion among physicians in donor selection or differences in donor motivations for blood donation. Most of the donors in our cen ters said that they wanted to donate blood for altruistic reasons,1818. Kasraian L, Maghsudlu M. Blood donors' attitudes towards incentives: influence on motivation to donate. Blood Transfus. 2012; 10(2):186-90. and some of them may have come for donation in spite of medi cal ineligibility for blood donation. This shows the importance of educating donors about donation criteria and the deferral period.

Some of the donor eligibility criteria in our center were different from those in other countries. For example, in our center, every sexual relationship outside of legal marriage was assumed to be an unsafe sexual contact even with use of protective devices (barrier methods like condoms). The deferral period for tattooing in our center according to our SOP is one year but, according to the American Red Cross criteria, if the tattoo was applied by a state-regulated entity using sterile needles and ink, this is acceptable for blood donation.1919. American Red Cross. Eligibility Criteria by Alphabetical Listing. Available from: http://www.redcrossblood.org/donating-blood/eligibility-requirements/eligibility-criteria-alphabetical-listing. Accessed in 2014 (Mar 11).
http://www.redcrossblood.org/donating-bl...
For acupuncture, the deferral period in our center is one year but again, according to the American Red Cross criteria, this is acceptable.1919. American Red Cross. Eligibility Criteria by Alphabetical Listing. Available from: http://www.redcrossblood.org/donating-blood/eligibility-requirements/eligibility-criteria-alphabetical-listing. Accessed in 2014 (Mar 11).
http://www.redcrossblood.org/donating-bl...
The deferral periods for dental procedures and dental surgery in our center are 3-8 days but, according to the American Red Cross criteria, the period is only three days.1919. American Red Cross. Eligibility Criteria by Alphabetical Listing. Available from: http://www.redcrossblood.org/donating-blood/eligibility-requirements/eligibility-criteria-alphabetical-listing. Accessed in 2014 (Mar 11).
http://www.redcrossblood.org/donating-bl...
The deferral period after antibiotic injection in our center is 28 days but, according to the American Red Cross criteria, it is only 10 days.1919. American Red Cross. Eligibility Criteria by Alphabetical Listing. Available from: http://www.redcrossblood.org/donating-blood/eligibility-requirements/eligibility-criteria-alphabetical-listing. Accessed in 2014 (Mar 11).
http://www.redcrossblood.org/donating-bl...
Some of the donors may come for blood donation during their deferral period and these donors may falsely increase the donor deferral rate.

Short-term deferrals accounted for 95.5% of all deferrals in our study. In a study by Custer et al., short-term deferral accounted for 68.5%;1515. Custer B, Johnson ES, Sullivan SD, et al. Quantifying losses to the donated blood supply due to donor deferral and miscollection. Transfusion. 2004;44(10):1417-26. in another study by Shaz et al. it was 68%;1616. Shaz BH, James AB, Hillyer KL, Schreiber GB, Hillyer CD. Demographic variations in blood donor deferrals in a major metropolitan area. Transfusion. 2010;50(4):881-7. and in a study by Lawson-Ayayi et al. in France, it was 91.3%.1717. Lawson-Ayayi S, Salmi LR. Epidemiology of blood collection in France. Eur J Epidemiol. 1999;15(3):285-92. These findings were different from our result.

In this study, the deferral rate was higher among females (39.9% versus 30.3%). Similar figures were reported from two studies in the United States and Turkey, in which females had a higher deferral rate,11. Newman B. Blood donor suitability and allogeneic whole blood donation. Transfus Med Rev. 2001;15(3):234-44. , 88. Arslan O. Whole blood donor deferral rate and characteristics of the Turkish population. Transfus Med. 2007;17(5):379-83. , 1616. Shaz BH, James AB, Hillyer KL, Schreiber GB, Hillyer CD. Demographic variations in blood donor deferrals in a major metropolitan area. Transfusion. 2010;50(4):881-7. while a study in France showed that greater numbers of female donors were temporarily deferred because of medical unsuitability for donation, but that there was no relationship with sex among the permanently-deferred donors.1717. Lawson-Ayayi S, Salmi LR. Epidemiology of blood collection in France. Eur J Epidemiol. 1999;15(3):285-92. This finding was parallel to our results. The higher deferral rate among females may have been because of the higher prevalence of iron deficiency anemia in women of reproductive age.

The most frequent reasons for deferral in our study were the presence of existing risk factors which may have been related to HIV or hepatitis infections (43.6%), underlying diseases (31.9%), non-eligible general conditions (13.5%), medications interfering with blood donation (7.8%) or risk factors relating to bacterial or viral infections except HIV and hepatitis infections (3.2%). In another study in Iran between 2002 to 2004, the most frequent reasons for deferral in seven blood centers were unsafe sexual contact (17.8%), medications that interfere with blood donation (12.3%) and hypotension (8.9%).2020. Maghsudlu M, Makipour M, Nasizadeh S. Evaluation of deferral causes of blood donors and relevant factors. The Scientific Journal of Iranian Blood Transfusion Organization. 20063(1):9-16. Available from: http://www.bloodjournal.ir/browse.php?a_id=63&sid=1&slc_lang=en. Accessed in 2014 (Mar 11).
http://www.bloodjournal.ir/browse.php?a_...
In another study by Cheraghali, which was carried out in Iran between 2002 and 2011, the most common reasons for deferral were low blood pressure, low hemoglobin and low weight.21 21. Cheraghali A. Overview of blood transfusion system of Iran: 2002-2011. Iran J Public Health. 2012;41(8):89-93.These findings were different from the reasons for deferral in our center. These differences may have been due to cultural differences, greater frequency of traveling to other countries for business reasons and presence of many universities that attract more young people for blood donation who may more frequently have high-risk behavior, stricter donor selection, more cautious donor selection or more comfort with regard to expressing high-risk behavior. In another study, the most common reasons for temporary deferral were low hemoglobin (Hb) (46%), common cold (19%) and elevated temperature (10%).2222. Halperin D, Baetens J, Newman B. The effect of short-term, temporary deferral on future blood donation. Transfusion. 1998;38(2):181-3. In a study by Lim et al., the most frequent reasons for deferral were drug consumption, influenza, low Hb, hypertension, and recent high-risk sexual activity.1414. Lim JC, Tien SL, Ong YW. Main causes of pre-donation deferral of prospective blood donors in the Singapore Blood Transfusion Service. Ann Acad Med Singapore. 1993;22(3):326-31. In another study by Custer et al., the main reasons for deferral were low Hb (60%), emigration from an area with malaria (59%) and tattoo or needle exposure (29%).1515. Custer B, Johnson ES, Sullivan SD, et al. Quantifying losses to the donated blood supply due to donor deferral and miscollection. Transfusion. 2004;44(10):1417-26. In a study on a Turkish population, the main reasons for short-term deferral were common cold in men and low hematocrit in women, while low hematocrit was the most common reason overall (20.07%), followed by common cold (17.7%), high-risk sexual activity (16.7%), hypertension (5.6%) and polycythemia (2.8%).88. Arslan O. Whole blood donor deferral rate and characteristics of the Turkish population. Transfus Med. 2007;17(5):379-83. In our study, the main reasons for deferral were risk of HIV or hepatitis infection in men (46.5%) and underlying diseases (60%), while 25.8% of the women were deferred because of anemia. This was similar to a study among Turkish donors in which the leading reasons for deferral were high-risk sexual activity (20.2%) in men and low Hb (51.6%) in women.88. Arslan O. Whole blood donor deferral rate and characteristics of the Turkish population. Transfus Med. 2007;17(5):379-83. The comparisons of deferral rates and the most common reasons for deferral in our study in relation to other studies are summarized in Table 4.

Table 4
Comparison of deferral rates and the most common reasons for deferral in our study, with other studies

The deferral rate was higher in donors aged 17-30 years in our study, as was also found in a study in France, in which 50% of the deferred donors were less than 35 years old,1717. Lawson-Ayayi S, Salmi LR. Epidemiology of blood collection in France. Eur J Epidemiol. 1999;15(3):285-92. whereas in a study in Turkey, the deferral rate was higher in the 50 to 65-year age group.88. Arslan O. Whole blood donor deferral rate and characteristics of the Turkish population. Transfus Med. 2007;17(5):379-83.

In our study, the deferral rate was also higher among first-time donors (48.1% versus 13.1%). This may have been because repeated donors have greater awareness about blood donation criteria, and it illustrates the importance of recruiting regular donors and educating the general population regarding the eligibility criteria for blood donation.

In this study, the most common reason for deferral among first-time donors was risk factors that might be related to HIV or hepatitis infection, while among donors with a history of previous donation, it was underlying diseases. This emphasizes the importance of recruiting repeated blood donors in order to ensure blood safety.

The deferral rate because of the risk of HIV or hepatitis infections among married donors was significantly lower than among single donors (21.07% versus 52.9%) in this study. This may have been because of the greater commitment to family life and values among married donors, or denial of high-risk behavior in this group.

In spite of deferral of 30.9% of donated blood, which led to discarding of blood units, the prevalence rates of HBS antigen (Ag), HCV antibody (Ab) and HIV Ag and Ab in Shiraz blood donors during the study period were low (0.29%, 0.15% and 0.01%, respectively). In other studies, the prevalence rates of HBS Ag, HCV Ab and HIV Ab in 2006 in western Ethiopia were 25%, 13.3% and 11.7%.2323. Dessie A, Abera B, Wale F. Seroprevalence of major blood-borne infections among blood donors at Felege Hiwot referral hospital, northwest Ethiopia. Ethiop J Health Dev. 2007;21(1):68-9. Available from: http://ejhd.uib.no/ejhd-v21-n1/68_69_EJHD_Vol_21-168_69_EJHD_Vol_21-1.pdf. Accessed in 2014 (Mar 11).
http://ejhd.uib.no/ejhd-v21-n1/68_69_EJH...
The prevalence rate of HBS Ag in volunteer Albanian blood donors was 7.9% in 2009.2424. Durro V, Qyra S. Trends in prevalence of hepatitis B virus infection among Albanian blood donors, 1999-2009. Virol J. 2011;8:96. The prevalence rates of HBS Ag, HCV Ab and HIV Ab in Filipino blood donors in 2002-2004 were 4.2%, 0.3% and 0.006%.2525. Yanase Y, Ohida T, Kaneita Y, et al. The prevalence of HIV, HBV and HCV among Filipino blood donors and overseas work visa applicants. Bull World Health Organ. 2007;85(2):131-7. In another study in northern India, the prevalence rate of HIV Ab was 0.234%.2626. Makroo RN, Chowdhry M, Bhatia A, Arora B, Rosamma NL. Prevalence of HIV among blood donors in a tertiary care centre of north India. Indian J Med Res. 2011;134(6):950-3. These figures were higher than in our study, which emphasizes that strict donor selection may have led to blood safety and lower prevalence rate of HBS, HCV and HIV in Shiraz donors.

Limitation

One of the limitations of this study was that we recorded rea sons for deferral from only one source (the donor database). This source only recorded the main reason, without mention ing all the reasons for deferral, even though in some cases there may have been some different reasons. Another limitation of our study was that some deferred donors may come back during their deferral period, thereby falsely increasing the deferral rate.

Donor deferral may discourage potential donors. A large number of deferred donors do not return to donate again because of negative feelings from deferral, regarding themselves and the blood donation process.1010. Agnihotri N. Whole blood donor deferral analysis at a center in Western India. Asian J Transfus Sci. 2010;4(2):116-22. , 1111. Sundar P, Sangeetha SK, Seema DM, Marimuthu P, Shivanna N. Pre-donation deferral of blood donors in South Indian set-up: An analysis. Asian J Transfus Sci. 2010;4(2):112-5. , 2727. Di Lorenzo Oliveira C, Loureiro F, de Bastos MR, Proietti FA, Carneiro-Proietti AB. Blood donor deferral in Minas Gerais State, Brazil: blood centers as sentinels of urban population health. Transfusion. 2009;49(5):851-7. Understanding the rates and reasons for deferral can help in planning recruitment programs and in obtaining more accurate estimates of the real eligible blood donor pool, which may vary considerably from the potential blood donor pool.1010. Agnihotri N. Whole blood donor deferral analysis at a center in Western India. Asian J Transfus Sci. 2010;4(2):116-22. Riley et al. showed that because of exclusion criteria, the real population of eligible blood donors is much lower than the presumed population based on age eligibility alone (17-65 years). These authors found that by taking into consideration all the donor criteria, the real donation eligible pool may reach around 59%.2828. Riley W, Schwei M, McCullough J. The Unite States' potential blood donor pool: estimating the prevalence of donor-exclusion factors on the pool of potential donors. Transfusion. 2007;47(7):1180-8. It is useful to determine and merge deferral rate data from all over the country in order to estimate the real eligible donation pool at the national level and plan future recruitment efforts.

It seems that in order to ensure adequate blood supply, we must encourage donors to donate blood only for altruistic reasons.2929. Kasraian L. Causes of discontinuity of blood donation among donors in Shiraz, Iran: cross-sectional study. Sao Paulo Med J. 2010;128(5):272-5. We must educate them regarding donation criteria. Physicians must give donors assurances regarding the confidentiality of donor selection so that potential donors answer the questions honestly.3030. Kasraian L, Tavasoli A. Positivity of HIV, hepatitis B and hepatitis C in patients enrolled in a confidential self-exclusion system of blood donation: a cross-sectional analytical study. Sao Paulo Med J. 2010;128(6):320-3. Physicians must also give assurances regarding the confidentially of the self-exclusion option for donors who divulge their high-risk behaviors.3030. Kasraian L, Tavasoli A. Positivity of HIV, hepatitis B and hepatitis C in patients enrolled in a confidential self-exclusion system of blood donation: a cross-sectional analytical study. Sao Paulo Med J. 2010;128(6):320-3. Blood centers must recruit first-time donors, maintain their existing donors and identify the barriers that impede donation.2929. Kasraian L. Causes of discontinuity of blood donation among donors in Shiraz, Iran: cross-sectional study. Sao Paulo Med J. 2010;128(5):272-5.

One of advantages of this study was the large sample size. Similar studies should be conducted in other parts of the country so that deferral rates and reasons can be identified at the national level.

CONCLUSIONS

Overall, donor deferral in our center is higher than in other stud ies, which shows the importance of evaluation of the donor selec tion process and donation criteria so that unnecessary deferral is prevented. Donor deferral leads to loss of many people from the donation pool because of concerns regarding the safety of blood for recipients. However, the actual benefits for recipient safety remain questionable. Effective measures need to be established in order to consider the effect of deferral on donor availability and donor return, and to monitor the effectiveness and necessity of deferrals and the reasons for them. Blood centers should explain the necessary donation criteria, the reason for the deferral, length of deferral and methods for preventing deferral in the future.

Acknowledgements:

We would like to thank Azadeh Mosallai for her help with data collection; Dr. Peyman Jafari for the data analysis; and Dr. Nasrin Shokrpoor and K. Shashok (author aid in the Eastern Mediterranean) for editing the manuscript

REFERENCES

  • 1
    Newman B. Blood donor suitability and allogeneic whole blood donation. Transfus Med Rev. 2001;15(3):234-44.
  • 2
    Zou S, Musavi F, Notari EP 4th, et al. Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study. Transfusion. 2005;45(10):1593-600.
  • 3
    Eder A, Bianco C. Screening blood donors: Science, reason, and the donor history questionnaire. Bethesda: American Association of Blood Banks; 2007.
  • 4
    Cable R, Musavi F, Notari E, Zou S, ARCNET Research Group. Limited effectiveness of donor deferral registries for transfusion-transmitted disease markers. Transfusion. 2008;48(1):34-42.
  • 5
    Zou S, Musavi F, Notari EP, et al. Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006. Transfusion. 2008;48(12):2531-9.
  • 6
    Katz L, Strong DM, Tegtmeier G, Stramer S. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen. Transfusion. 2008;48(11):2315-22.
  • 7
    Wu Y, Glynn SA, Schreiber GB, et al. First-time blood donors: demographic trends. Transfusion. 2001;41(3):360-4.
  • 8
    Arslan O. Whole blood donor deferral rate and characteristics of the Turkish population. Transfus Med. 2007;17(5):379-83.
  • 9
    Brecher MG. AABB technical manual. 15th edition. Bethesda: AABB Press; 2005.
  • 10
    Agnihotri N. Whole blood donor deferral analysis at a center in Western India. Asian J Transfus Sci. 2010;4(2):116-22.
  • 11
    Sundar P, Sangeetha SK, Seema DM, Marimuthu P, Shivanna N. Pre-donation deferral of blood donors in South Indian set-up: An analysis. Asian J Transfus Sci. 2010;4(2):112-5.
  • 12
    Chaudhary RK, Gupta D, Gupta RK. Analysis of donor-deferral pattern in a voluntary blood donor population. Transfus Med. 1995;5(3):209-12.
  • 13
    Bahadur S, Jain S, Goel RK, Pahuja S, Jain M. Analysis of blood donor deferral characteristics in Delhi, India. Southeast Asian J Trop Med Public Health. 2009;40(5):1087-91.
  • 14
    Lim JC, Tien SL, Ong YW. Main causes of pre-donation deferral of prospective blood donors in the Singapore Blood Transfusion Service. Ann Acad Med Singapore. 1993;22(3):326-31.
  • 15
    Custer B, Johnson ES, Sullivan SD, et al. Quantifying losses to the donated blood supply due to donor deferral and miscollection. Transfusion. 2004;44(10):1417-26.
  • 16
    Shaz BH, James AB, Hillyer KL, Schreiber GB, Hillyer CD. Demographic variations in blood donor deferrals in a major metropolitan area. Transfusion. 2010;50(4):881-7.
  • 17
    Lawson-Ayayi S, Salmi LR. Epidemiology of blood collection in France. Eur J Epidemiol. 1999;15(3):285-92.
  • 18
    Kasraian L, Maghsudlu M. Blood donors' attitudes towards incentives: influence on motivation to donate. Blood Transfus. 2012; 10(2):186-90.
  • 19
    American Red Cross. Eligibility Criteria by Alphabetical Listing. Available from: http://www.redcrossblood.org/donating-blood/eligibility-requirements/eligibility-criteria-alphabetical-listing. Accessed in 2014 (Mar 11).
    » http://www.redcrossblood.org/donating-blood/eligibility-requirements/eligibility-criteria-alphabetical-listing
  • 20
    Maghsudlu M, Makipour M, Nasizadeh S. Evaluation of deferral causes of blood donors and relevant factors. The Scientific Journal of Iranian Blood Transfusion Organization. 20063(1):9-16. Available from: http://www.bloodjournal.ir/browse.php?a_id=63&sid=1&slc_lang=en. Accessed in 2014 (Mar 11).
    » http://www.bloodjournal.ir/browse.php?a_id=63&sid=1&slc_lang=en
  • 21
    Cheraghali A. Overview of blood transfusion system of Iran: 2002-2011. Iran J Public Health. 2012;41(8):89-93.
  • 22
    Halperin D, Baetens J, Newman B. The effect of short-term, temporary deferral on future blood donation. Transfusion. 1998;38(2):181-3.
  • 23
    Dessie A, Abera B, Wale F. Seroprevalence of major blood-borne infections among blood donors at Felege Hiwot referral hospital, northwest Ethiopia. Ethiop J Health Dev. 2007;21(1):68-9. Available from: http://ejhd.uib.no/ejhd-v21-n1/68_69_EJHD_Vol_21-168_69_EJHD_Vol_21-1.pdf. Accessed in 2014 (Mar 11).
    » http://ejhd.uib.no/ejhd-v21-n1/68_69_EJHD_Vol_21-168_69_EJHD_Vol_21-1.pdf
  • 24
    Durro V, Qyra S. Trends in prevalence of hepatitis B virus infection among Albanian blood donors, 1999-2009. Virol J. 2011;8:96.
  • 25
    Yanase Y, Ohida T, Kaneita Y, et al. The prevalence of HIV, HBV and HCV among Filipino blood donors and overseas work visa applicants. Bull World Health Organ. 2007;85(2):131-7.
  • 26
    Makroo RN, Chowdhry M, Bhatia A, Arora B, Rosamma NL. Prevalence of HIV among blood donors in a tertiary care centre of north India. Indian J Med Res. 2011;134(6):950-3.
  • 27
    Di Lorenzo Oliveira C, Loureiro F, de Bastos MR, Proietti FA, Carneiro-Proietti AB. Blood donor deferral in Minas Gerais State, Brazil: blood centers as sentinels of urban population health. Transfusion. 2009;49(5):851-7.
  • 28
    Riley W, Schwei M, McCullough J. The Unite States' potential blood donor pool: estimating the prevalence of donor-exclusion factors on the pool of potential donors. Transfusion. 2007;47(7):1180-8.
  • 29
    Kasraian L. Causes of discontinuity of blood donation among donors in Shiraz, Iran: cross-sectional study. Sao Paulo Med J. 2010;128(5):272-5.
  • 30
    Kasraian L, Tavasoli A. Positivity of HIV, hepatitis B and hepatitis C in patients enrolled in a confidential self-exclusion system of blood donation: a cross-sectional analytical study. Sao Paulo Med J. 2010;128(6):320-3.
  • Sources of funding: None

Publication Dates

  • Publication in this collection
    22 Aug 2014
  • Date of issue
    Jan-Fev 2015

History

  • Received
    07 May 2013
  • Reviewed
    16 Apr 2014
  • Accepted
    06 June 2014
Associação Paulista de Medicina - APM APM / Publicações Científicas, Av. Brigadeiro Luís Antonio, 278 - 7º and., 01318-901 São Paulo SP - Brazil, Tel.: +55 11 3188-4310 / 3188-4311, Fax: +55 11 3188-4255 - São Paulo - SP - Brazil
E-mail: revistas@apm.org.br